
Metrolax 25 Tablet ER
Marketer
Cardivista
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Metrolax 25 Tablet ER
CardioBlock 25 Extended-Release tablets are a beta-blocker medication indicated for managing hypertension, angina pectoris, and cardiac arrhythmias. This medication also aids in migraine prophylaxis and reducing the risk of future strokes and myocardial infarctions. CardioBlock 25 ER may be administered independently or in conjunction with other therapies, with dosage and frequency tailored to individual needs and condition severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefits may take several weeks to manifest, and continuous use, even with symptom improvement, is often necessary. Discontinuation can lead to condition exacerbation. Common, usually transient, adverse effects include fatigue, cephalalgia, depressive symptoms, diarrhea, skin rash, bradycardia, dizziness, and nausea. Less frequently, shortness of breath or hypotension may occur. Gradual dose escalation minimizes side effects. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose any hepatic impairment, bradycardia, severe peripheral vascular disease, severe congestive heart failure, or hypotension. Pregnant or lactating individuals require physician consultation. A thorough assessment of suitability is essential. Regular blood pressure monitoring ensures treatment effectiveness. Alcohol consumption should be limited due to potential side effect exacerbation.
Uses of Metrolax 25 Tablet ER
Managing angina pectoris (chest pain of cardiac origin) | Cardiac arrhythmia management | Mitigation of myocardial infarction (heart attack) | Hypertension (high blood pressure) therapy | Migraine prophylaxis
Major Benefits of Metrolax 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Metrolax 25 Tablet ER can be administered with or without food, however, consistent timing is recommended. Limit consumption of high-fat foods, including olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and fatty meats, while taking Metrolax 25 Tablet ER.
Common Side effects of Metrolax 25 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metrolax 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metrolax 25 Tablet ER whole; do not crush, chew, or divide it. It can be taken with or without food, but consistency in timing is recommended. For optimal absorption, avoid consuming Metrolax 25 Tablet ER with meals high in fat, including those containing olive oil, nuts (like Brazil nuts), dark chocolate, butter, or meat.
How Metrolax 25 Tablet ER works:
Cardio-selective extended-release Metrolax 25mg tablets reduce cardiac workload. This effect is achieved by decreasing heart rate and improving the efficiency of blood circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metrolax 25 Tablet ER and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Metrolax 25 Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Consult your doctor for advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metrolax 25mg tablets are likely safe for use while breastfeeding. Available evidence from human studies indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metrolax 25 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if you experience these effects.
KidneySAFE IF PRESCRIBED
Extended-release Metrolax 25 tablets are considered safe for use in individuals with renal impairment. No alteration of the Metrolax 25 ER dosage is necessary.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using extended-release Metrolax 25 mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Metrolax 25 Tablet ER :
Should you forget a Metrolax 25 Tablet ER dose, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Metrolax 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
